Clinical trialNCT07027514RecruitingPhase 1Interventional

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

SponsorAnkyra Therapeutics, IncEnrollment60Non Small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Community Health Network
Indianapolis, Indiana, United States
Neil Shukla, M.D.
Recruiting
Barbara Ann Karmanos Cancer Hospital
Detroit, Michigan, United States
Tarik Hadid, M.D.
Recruiting
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States
Prantesh Jain, M.D.
Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Thomas Marron, M.D.
Recruiting
Firsthealth of the Carolinas
Pinehurst, North Carolina, United States
Michael Pritchett, D.O.
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Oct 2025
Primary completion: 30 Jun 2027
Completion: 31 Dec 2028
Last update posted: 18 Nov 2025
Registered enrollment: 60
Registry id: NCT07027514

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.